Appreciating HIV type 1 diversity: subtype differences in Env.
about
HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIVNeutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from IndiaSubtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.HIV-1 Populations in Semen Arise through Multiple Mechanisms.Donor and recipient envs from heterosexual human immunodeficiency virus subtype C transmission pairs require high receptor levels for entryGenetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates.Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry.Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies.The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progressionA single amino acid substitution in the C4 region in gp120 confers enhanced neutralization of HIV-1 by modulating CD4 binding sites and V3 loop.A mechanistic understanding of allosteric immune escape pathways in the HIV-1 envelope glycoprotein.Structural basis of clade-specific HIV-1 neutralization by humanized anti-V3 monoclonal antibody KD-247.Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting VirusesInvestigation of Human Cancers for Retrovirus by Low-Stringency Target Enrichment and High-Throughput SequencingProfile of T cell recognition of HIV type 1 consensus group M Gag and Nef peptides in a clade A1- and D-infected Ugandan population.Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization BreadthProduction and characterization of human anti-V3 monoclonal antibodies from the cells of HIV-1 infected Indian donors.The Genetic Diversity and Evolution of HIV-1 Subtype B Epidemic in Puerto RicoSubtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection.Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals.Subtype B was the dominant strain among HIV type 1 infections except for the population of men who have sex with men in Harbin City, China.Inference of global HIV-1 sequence patterns and preliminary feature analysis.Identification of a novel HIV-1-neutralizing antibody from a CRF07_BC-infected Chinese donor.Longitudinal HIV-1 gp120-C2V3C3 phylogenetic surveillance and tropism evolution in patients under HAART.HIV-infection resistance in PMBC-derived dendritic cells modified with recombinant virus.Relative reactivity of HIV-1 polyclonal plasma antibodies directed to V3 and MPER regions suggests immunodominance of V3 over MPER and dependence of high anti-V3 antibody titers on virus persistence.Mapping mutational effects along the evolutionary landscape of HIV envelope.
P2860
Q27497560-29DB319E-A220-4249-8C62-EC8ABB4FF061Q28483205-D93AEBCA-EA2B-456C-AF68-DD0BC02C0AECQ28542806-82347446-6CDC-49B7-8C9B-1B8295341C63Q33504599-E093EF57-B083-4A21-9439-47C6B723F2C9Q33680752-5479B86B-E315-4520-94D6-F020A53708ADQ33769382-2359A4BA-6CE2-45CB-B4FF-B64BF38BE028Q33851789-614751F1-C16D-42A8-91FA-3092898254F5Q33857491-28F7FB67-7AF2-4285-9289-F2539533623DQ33877434-7406B8F1-33C5-46F0-9C0A-A15B88A2DF0BQ34303849-5EF80D4D-BE8B-48E0-86D8-FC227319BD15Q34350944-0402A563-09ED-433F-8E6C-80C5E485EFDAQ34463861-12FD26F6-955F-48D4-AAA7-098B95AA7162Q34733504-B5B55626-4871-4CF2-B298-A10251F42B83Q34847834-FEC13D97-24AE-461B-A534-4A2F2B75A255Q34948847-D973AEF9-F986-45D8-83E4-C778C609AFCDQ35749247-15D970C4-94F5-425F-9F82-8B1652BC52F6Q35862305-06B8FEBF-1223-437C-8629-ECB85222F57EQ36194234-46AD6585-18AC-468E-96A2-44A66EE37CEFQ36384117-D34091FF-5EB9-4D18-AC01-3E662613BC54Q36513021-DFA584BF-6930-40B8-8587-DC4240164F60Q37704735-366906C7-02D0-4FD5-A540-0890C426538DQ40178574-91E1A687-2C36-444D-8516-8BDDAAAC7215Q42021234-30C2E5E3-DAF0-4008-9187-E03D9D03A0D8Q42279217-65DB2046-8CAC-478A-A925-94CBD7EA6652Q42362648-DD3D5F1F-B3BA-4144-BB57-B229CEEF5439Q44592371-DC5592C3-1CEA-40E7-A42A-9BA6050AE880Q45361127-6BC44582-6E98-4BE2-B175-87E39A1DB625Q45365167-ADF5A79C-EAC0-4F9B-849C-A9198767BDF8Q54246851-351901DB-058B-4275-81DA-C7823E772089
P2860
Appreciating HIV type 1 diversity: subtype differences in Env.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Appreciating HIV type 1 diversity: subtype differences in Env.
@ast
Appreciating HIV type 1 diversity: subtype differences in Env.
@en
type
label
Appreciating HIV type 1 diversity: subtype differences in Env.
@ast
Appreciating HIV type 1 diversity: subtype differences in Env.
@en
prefLabel
Appreciating HIV type 1 diversity: subtype differences in Env.
@ast
Appreciating HIV type 1 diversity: subtype differences in Env.
@en
P2860
P356
P1476
Appreciating HIV type 1 diversity: subtype differences in Env.
@en
P2093
Cynthia A Derdeyn
Rebecca M Lynch
P2860
P304
P356
10.1089/AID.2008.0219
P577
2009-03-01T00:00:00Z